Liquid Biopsy Monitoring in BRAF V600E–Mutated Patients With Non–Small Cell Lung Cancer Treated With Dabrafenib Plus Trametinib: The Prospective, Multicenter LiBRA Study (GOIRC-03-2020)

JCO Precision Oncology · Published 2026-06-01 · DOI 10.1200/po-25-01107

Authors (29)

Alessandro Leonetti, Monica Pluchino, Roberta Minari, Francesco Passiglia, Elio Gregory Pizzutilo, Diego Luigi Cortinovis, Luca Toschi, Francesco Gelsomino, Stefano Frega, Giulio Metro, Lorenzo Belluomini, Michele Montrone, Andrea Camerini, Alessandro Bertolini, Editta Baldini, Francesca Mazzoni, Emilio Bria, Federica Bertolini, Alessandro Del Conte, Paola Bordi, Fabiana Perrone, Michela Verzè, Simona D'Agnelli, Paola Onorini, Agnese Cosenza, Francesco Facchinetti, Luca Boni, Michele Tognetto, Marcello Tiseo

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Leonetti, A., Pluchino, M., Minari, R., et al. (2026). Liquid Biopsy Monitoring in BRAF V600E–Mutated Patients With Non–Small Cell Lung Cancer Treated With Dabrafenib Plus Trametinib: The Prospective, Multicenter LiBRA Study (GOIRC-03-2020). JCO Precision Oncology. https://doi.org/10.1200/po-25-01107

Related articles